M&A Corner
Soaak Technologies Announces Acquisition of Tulsa Natural Health Clinic, for its’ Global and Digital Expansion21 Feb 2024
Soaak Technologies acquires Tulsa Natural Health Clinic, merging advanced health-tech with naturopathic expertise to redefine global wellness. The move expands... Continue Reading
|
Zeda Announces Acquisition of The Orthopaedic Implant Company21 Feb 2024
Zeda, Inc. acquires The Orthopaedic Implant Company (OIC), a leader in value-based orthopaedic implants, marking a significant advancement in Zeda’s... Continue Reading
|
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.21 Feb 2024
BioVaxys Technology Corp. finalizes the acquisition of IMV Inc.’s DPX™ immune educating platform, expanding its oncology, infectious disease, and immunology... Continue Reading
|
Tyber Medical Acquires FDA Clearance for Proximal Tibia Plating System21 Feb 2024
Tyber Medical LLC secures FDA 510(k) approval for its Proximal Tibia Plating System, catering to complete and partial articular fractures.... Continue Reading
|
Freeline Shareholders Approve Acquisition by Syncona.21 Feb 2024
Freeline Therapeutics Holdings plc shareholders have approved Syncona Ltd’s subsidiary Bidco’s acquisition proposal for $6.50 per American Depositary Share (ADS)... Continue Reading
|
Sentrex Health Solutions Inc. Expands Innovative Healthcare Services with Strategic Acquisition of PerCuro Clinical Research Ltd.21 Feb 2024
Sentrex Health Solutions Inc. acquires PerCuro Clinical Research Ltd., enhancing its specialty healthcare services in Canada. PerCuro’s nurse-led model expands... Continue Reading
|
Cryotherapy Technology Company Vessi Medical Scores $16.5M and More Digital Health Fundings21 Feb 2024
Vessi Medical secures $16.5M in Series A funding for its cryotherapy technology targeting non-muscle invasive bladder cancer (NMIBC). The Israeli... Continue Reading
|
Headlight Mental Health Scores $18M to Expand Teletherapy, In-Person Care21 Feb 2024
Headlight, a mental health practice, secures $18M in funding led by Matrix and EPIC Ventures, aiming to expand across states... Continue Reading
|
Freenome Raises $254M to Accelerate Early Cancer Detection Platform21 Feb 2024
Freenome secures $254M in funding led by Roche, alongside various prominent investors, to advance its blood-based early cancer detection technology.... Continue Reading
|
Gilead to Buy CymaBay, Lead Liver Disease Asset Seladelpar for $4.3B21 Feb 2024
Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion, gaining access to seladelpar, a promising treatment for primary biliary cholangitis (PBC).... Continue Reading
|